Caduet Tablet, Film Coated
Product Images NDC 58151-067

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Caduet (NDC 58151-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Caduet 01)

Chemical structure of the active ingredient in Caduet, showing a chlorinated aromatic ring and several functional groups including ethers and amides, with molecular formula C8H8O3 indicated in the diagram.*

FDA Label Image

Chemical Structure (Caduet 02)

Chemical structure of the active ingredient in Caduet, showing a complex molecular arrangement including phenyl, fluorophenyl groups, and calcium with three water molecules (Ca2+ · 3H2O) indicated.*

FDA Label Image

Figure 1 (Caduet 03)

A Kaplan-Meier plot comparing event rates over 24 months between patients treated with Amlodipine and those receiving placebo. The x-axis represents time in months and the y-axis shows the event rate. The graph includes statistical data with a P-value of 0.003, hazard ratio of 0.691, and 95% confidence interval of 0.54 to 0.88. Numbers at risk are indicated below the time axis.*

FDA Label Image

Figure 2 (Caduet 04)

A hazard ratio plot with 95% confidence intervals comparing outcomes between Amlodipine and placebo. It displays data for overall patients and subgroups by age, gender, baseline sitting systolic blood pressure, baseline vessel disease status, stenosis presence, and PCI-stent strata. The horizontal axis represents hazard ratio values from 0.0 to 2.0, with a vertical reference line at 1.0.*

FDA Label Image

Figure 3 (Caduet 05)

A line graph depicting cumulative incidence (%) over time in years up to 3.5 years, comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, and the dashed line represents Placebo. The graph shows lower cumulative incidence for Atorvastatin with a hazard ratio (HR) of 0.64 (95% CI 0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure 4 (Caduet 06)

A line chart showing cumulative hazard percentage over time up to 4 years of follow-up comparing placebo and atorvastatin. The x-axis represents time to first primary endpoint in years, and the y-axis represents cumulative hazard percentage. The atorvastatin line shows a lower cumulative hazard compared to placebo throughout the follow-up period.*

FDA Label Image

Figure 5 (Caduet 07)

A line graph comparing the percentage of subjects experiencing the first major cardiovascular endpoint over five years between two doses of Atorvastatin, 10 mg and 80 mg. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicated.*

FDA Label Image

Principal Display Panel (5 mg/10 mg Tablet Bottle Label)

Label for Caduet tablets containing amlodipine and atorvastatin with a strength of 5 mg/10 mg. The label indicates a 30-tablet count and is distributed by Viatris Specialty LLC, Morgantown, WV. Storage instructions and dosage details appear. The label includes barcodes and a data matrix area for scanning.*

FDA Label Image

Principal Display Panel (5 mg/20 mg Tablet Bottle Label)

Label for Caduet tablets containing amlodipine and atorvastatin, strength 5 mg/20 mg. The label includes storage instructions, dosage directions referencing prescribing information, manufacturer Viatris Specialty LLC, and states the package contains 30 tablets. The label also shows a barcode, NDC 58151-065-93, and a Data Matrix area.*

FDA Label Image

Principal Display Panel (5 mg/40 mg Tablet Bottle Label)

Label for Caduet tablets containing 5 mg amlodipine and 40 mg atorvastatin. The label shows the proprietary name Caduet with active ingredients amlodipine and atorvastatin, dosage strength 5 mg/40 mg, and package size of 30 tablets. It is distributed by Viatris Specialty LLC, made in Germany, with storage instructions and barcode visible.*

FDA Label Image

Principal Display Panel (5 mg/80 mg Tablet Bottle Label)

Label for Caduet 5 mg/80 mg tablets, containing amlodipine and atorvastatin. The label shows the dosage strength, quantity of 30 tablets, and distribution by Viatris Specialty LLC. It includes storage instructions and a barcode, GTIN, and lot information sections.*

FDA Label Image

Principal Display Panel (10 mg/10 mg Tablet Bottle Label)

Label for Caduet tablets containing 10 mg amlodipine and 10 mg atorvastatin. The label indicates the dosage form as tablets with a quantity of 30 tablets. It bears the labeler name Viatris Specialty LLC, mentions storage instructions, and includes barcodes, lot, and expiration information. The product is made in Germany.*

FDA Label Image

Principal Display Panel (10 mg/20 mg Tablet Bottle Label)

Label for Caduet tablets containing 10 mg amlodipine and 20 mg atorvastatin. The label indicates a 30-tablet package, distributed by Viatris Specialty LLC, Morgantown, WV, and manufactured in Germany. The label also includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (10 mg/40 mg Tablet Bottle Label)

Caduet 10 mg/40 mg tablets label showing the combination of amlodipine and atorvastatin. The label states a package count of 30 tablets and is distributed by Viatris Specialty LLC. Storage instructions and dosage guidance refer to accompanying prescribing information. The label includes a barcode and expiration, lot, and serial number fields.*

FDA Label Image

Principal Display Panel (10 mg/80 mg Tablet Bottle Label)

Packaging label for Caduet tablets containing 10 mg amlodipine and 80 mg atorvastatin. The label shows dosage form as tablets, package count of 30 tablets, and is labeled by Viatris Specialty LLC. Storage instructions, dosage and use guidance, and distribution details including Made in Germany are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.